Evidence map›Paper›PMID 22045733›Full record

ArticleJournal of cell science2011

Peroxiredoxin-controlled G-CSF signalling at the endoplasmic reticulum-early endosome interface.

Karishma Palande, Onno Roovers, Judith Gits, Carola Verwijmeren, Yoshihito Iuchi, Junichi Fujii, Benjamin G Neel, Robert Karisch, Jan Tavernier, Ivo P Touw

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cell science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Stay in touch with the endoplasmic reticulum.Science China. Life sciences · 2024
    Pooled it
  2. Review
  3. Article
  4. Exploiting Connections for Viral Replication.Frontiers in cell and developmental biology · 2021
    Article
  5. Endosomes as Signaling Platforms for IL-6 Family Cytokine Receptors.Frontiers in cell and developmental biology · 2021
    Review
  6. ER morphology and endo-lysosomal crosstalk: Functions and disease implications.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2020
    Review
  7. Review
  8. Review
  9. PRDX4 and Its Roles in Various Cancers.Technology in cancer research & treatment · 2019
    Review
  10. Activity-dependent bulk endocytosis proteome reveals a key presynaptic role for the monomeric GTPase Rab11.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. The effect of peroxiredoxin 4 on fly physiology is a complex interplay of antioxidant and signaling functions.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Karishma PalandeDepartment of Hematology, Erasmus University Medical Center, 3015 GE Rotterdam, The Netherlands.
Onno Roovers
Judith Gits
Carola Verwijmeren
Yoshihito Iuchi
Junichi Fujii
Benjamin G Neel
Robert Karisch
Jan Tavernier
Ivo P Touw
Erasmus MC · NLYamagata University · JPGhent University · BEPrincess Margaret Cancer Centre · CAUniversity of Toronto · CA

Funding

Signal Transduction by Non-transmembrane PTPsR37CA049152 · NCI · UNIVERSITY HEALTH NETWORK · PI NEEL, BENJAMIN G. · 2004 to 2013
$4.0M
NCI NIH HHS R37 CA049152NCI NIH HHS R37 CA49132
6 · The paper itself

Abstract

Reactive oxygen species (ROS) regulate growth factor receptor signalling at least in part by inhibiting oxidation-sensitive phosphatases. An emerging concept is that ROS act locally to affect signal transduction in different subcellular compartments and that ROS levels are regulated by antioxidant proteins at the same local level. Here, we show that the ER-resident antioxidant peroxiredoxin 4 (Prdx4) interacts with the cytoplasmic domain of the granulocyte colony-stimulating factor receptor (G-CSFR). This interaction occurs when the activated G-CSFR resides in early endosomes. Prdx4 inhibits G-CSF-induced signalling and proliferation in myeloid progenitors, depending on its redox-active cysteine core. Protein tyrosine phosphatase 1b (Ptp1b) appears to be a major downstream effector controlling these responses. Conversely, Ptp1b might keep Prdx4 active by reducing its phosphorylation. These findings unveil a new signal transduction regulatory circuitry involving redox-controlled processes in the ER and activated cytokine receptors in endosomes.

Indexed as

Down-RegulationSignal TransductionAnimalsCell LineCell ProliferationEndoplasmic ReticulumEndosomesGranulocyte Colony-Stimulating FactorHematopoietic Stem CellsHumansMicePeroxiredoxinsPhosphorylationProtein BindingProtein Structure, TertiaryProtein Tyrosine Phosphatase, Non-Receptor Type 1Granulocyte Colony-Stimulating FactorPeroxiredoxinsPRDX4 protein, humanProtein Tyrosine Phosphatase, Non-Receptor Type 1PTPN1 protein, humanReactive Oxygen SpeciesReceptors, Granulocyte Colony-Stimulating Factor

Identifiers

PMID22045733
PMCPMC3215578
OpenAlexW2140460063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.